1. Volume 146, Issue 1, Pages 52-57 (July 2017)
Prognostic value of miliary versus non-miliary sub-staging in advanced ovarian cancer 
Kevin H. Eng, Kayla Morrell, Kristen Starbuck, Chandra Spring-Robinson, Aalia Khan, Dana Cleason, Levent Akman, Emese Zsiros, Kunle Odunsi, J. Brian Szender 
Gynecologic Oncology 
Volume 146, Issue 1, Pages (July 2017)
DOI: /j.ygyno
Copyright © 2017 The Authors Terms and Conditions

2. Fig. 1
Representative laparoscopic views showing tumor bulk above retracted mesentery (A), pooled ascites below peritoneal miliary disease (B) and a representative gradient of miliary disease to confluent plaque again with ascites (C).
Gynecologic Oncology  , 52-57DOI: ( /j.ygyno )
Copyright © 2017 The Authors Terms and Conditions

3. Fig. 2
Prognosis following surgery for patients with miliary (orange) versus non-miliary (blue) ovarian cancer stratified by stage shows miliary disease is a strong predictor of poor clinical outcome.
Gynecologic Oncology  , 52-57DOI: ( /j.ygyno )
Copyright © 2017 The Authors Terms and Conditions

4. Fig. 3
Correlations between organ site involvement and prevalence (A) with miliary disease (B) affect overall survival (C), progression-free survival (D) and time after relapse (E). Organ involvement counts only the liver, stomach, spleen, and bladder.
Gynecologic Oncology  , 52-57DOI: ( /j.ygyno )
Copyright © 2017 The Authors Terms and Conditions